文献速递皮肤肿瘤

候选基因法评估结节性黑色素瘤遗传风险

Assessing the genetic risk of nodular melanoma using a candidate gene approach.
PubMed 文献 · Br J Dermatol · 2024-01-01

本研究对131例结节性黑色素瘤(NM)和194例非NM患者进行500个候选基因的全外显子罕见变异等位基因分析,发现NM中最常见罕见变异的基因包括PTCH1、ARID2和GHR,携带两个NM相关基因罕见变异时NM相对于非NM的比值增加14.8倍,提示Hedgehog通路可能贡献NM风险。

要点

  • NM患者多为老年男性,浅肤色和红发频率高于一般人群。
  • NM与非NM的常见黑色素瘤多基因风险评分分布相似,最高分位均超过28%。
  • 携带两个NM相关基因罕见变异时,NM相对于非NM的比值增加14.8倍。

核心结论

  • 除已知高外显率基因外,考虑罕见变异等位基因频率有助于识别NM风险个体。

研究设计与样本

  • 研究纳入131例NM和194例非NM患者,对500个候选基因进行全外显子罕见变异等位基因分析(次要等位基因频率≤1%非芬兰欧洲人群)。

主要发现

  • NM患者中大多数为老年男性,浅肤色和红发频率高于一般人群。
  • NM与非NM患者的常见黑色素瘤多基因风险评分分布相似,最高分位均超过28%。
  • NM与非NM患者携带家族性/高外显率黑色素瘤基因及功能丧失变异的频率相似。
  • 按NM相对非NM频率最高筛选出39个基因,NM中罕见变异频率最高的基因包括PTCH1、ARID2和GHR。
  • 识别出与PTCH1相互作用的SMO基因罕见变异,提供Hedgehog通路可能贡献NM风险的证据。

关键数值与推荐

  • 携带两个NM相关基因罕见变异时,NM相对于非NM的比值增加14.8倍。

临床怎么用

  • 在评估NM遗传风险时,除已知高外显率基因外,可考虑罕见变异等位基因频率。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nodular melanoma (NM) is a challenge to diagnose early due to its rapid growth and more atypical clinical presentation, making it the largest contributor to melanoma mortality. OBJECTIVES: Our study aim was to perform a rare-variant allele (RVA) analysis of whole-exome sequencing of patients with NM and non-NM (minor allele frequency ≤ 1% non-Finnish European) for a set of 500 candidate genes potentially implicated in melanoma. METHODS: This study recruited 131 participants with NM and 194 with non-NM from South-east Queensland and patients with NM from Victoria to perform a comparative analysis of possible genetic differences or similarities between the two melanoma cohorts. RESULTS: Phenotypic analysis revealed that a majority of patients diagnosed with NM were older males with a higher frequency of fair skin and red hair than is seen in the general population. The distribution of common melanoma polygenic risk scores was similar in patients with NM and non-NM, with over 28% in the highest quantile of scores. There was also a similar frequency of carriage of familial/high-penetrant melanoma gene and loss-of-function variants. We identified 39 genes by filtering 500 candidate genes based on the greatest frequency in NM compared with non-NM cases. The genes with RVAs of greatest frequency in NM included PTCH1, ARID2 and GHR. Rare variants in the SMO gene, which interacts with PTCH1 as ligand and receptor, were also identified, providing evidence that the Hedgehog pathway may contribute to NM risk. There was a cumulative effect in carrying multiple rare variants in the NM-associated genes. A 14.8-fold increased ratio for NM compared with non-NM was seen when two RVAs of the 39 genes were carried by a patient. CONCLUSIONS: This study highlights the importance of considering frequency of RVA to identify those at risk of NM in addition to known high penetrance genes.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Stark MS, Sturm RA, Pan Y, et al. Assessing the genetic risk of nodular melanoma using a candidate gene approach. Br J Dermatol. 2024. PMID: 37766469. doi:10.1093/bjd/ljad365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。